Surgical control of obesity and diabetes: The role of intestinal vs. gastric mechanisms in the regulation of body weight and glucose homeostasis

Obesity

Volumn 22, Issue 1, 2014, Pages 159-169

  Patel, Rajesh T ^a   Shukla, Alpana P ^a   Ahn, Soo Min ^a   Moreira, Marlus ^a   Rubino, Francesco ^a,b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; PEPTIDE YY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DUODENAL JEJUNAL BYPASS; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HORMONE RESPONSE; INTERMETHOD COMPARISON; INTESTINE BYPASS; MALE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; RAT; SLEEVE GASTRECTOMY; WEIGHT CHANGE; WEIGHT CONTROL; WEIGHT GAIN; WEIGHT REDUCTION; ZUCKER DIABETIC FATTY RAT;

ANIMALIA; RATTUS;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DUODENUM; GASTRECTOMY; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; INSULIN; JEJUNOILEAL BYPASS; JEJUNUM; MALE; OBESITY; PEPTIDE YY; POSTOPERATIVE CARE; RATS;

EID: 84892372944     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20441     Document Type: Article

References (40)

1. Kopelman PG,. Obesity as a medical problem. Nature 2000; 404: 635-643
2. Zimmet P,. The burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003; 29: 6S9-6S18.
3. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693.
4. Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care 2005; 28: 2406-2411.
5. Rubino F, Schauer PR, Kaplan LM, Cummings DE,. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010; 61: 393-411.
6. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567-1576.
7. Breen DM, Rasmussen BA, Kokorovic A, et al. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med 2012; 18: 950-955.
8. Chambers AP, Jessen L, Ryan KK, et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology 2011; 141: 950-958.
9. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741-749.
10. Klein S, Fabbrini E, Patterson BW, et al. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity (Silver Spring) 2012; 20: 1266-1272.
11. Cohen RV, Schiavon CA, Pinheiro JS, et al. Duodenaljejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases. Surg Obes Relat Dis 2007; 3: 195-197.
12. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577-1585.
13. Thaler JP, Cummings DE,. Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009; 150: 2518-2525.
14. Shukla A, Rubino F,. Secretion and function of gastrointestinal hormones after bariatric surgery: their role in type 2 diabetes. Can J Diabetes 2011; 35: 115-122.
15. Holst JJ,. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439.
16. Drucker DJ,. The role of gut hormones in glucose homeostasis. J Clin Invest 2007; 117: 24.
17. Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 2009; 17: 1671-1677.
18. Simonen M, Dali-Youcef N, Kaminska D, et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg 2012; 22: 1473-1480.
19. Santacruz A, Marcos A, Wärnberg J, et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring) 2009; 17: 1906-1915.
20. Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010; 59: 3049-3057.
21. Lam TK,. Neuronal regulation of homeostasis by nutrient sensing. Nat Med 2010; 16: 392-395.
22. Moo TA, Rubino F,. Gastrointestinal surgery as treatment for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 2008; 15: 153-158.
23. Rubino F,. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. 2008;(Suppl 2): S290-S296.
24. Rubino F, R'bibo SL, delGenio F, et al. Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol 2010; 6: 102-109.
25. Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, et al. Sleevegastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 2010; 20: 535-540.
26. Rubino F, Marescaux J,. Effect of duodenal-jejunal exclusion in a nonobese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239: 1-11.
27. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
28. Cummings DE, Overduin J, Foster-Schubert KE, et al. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis 2007; 3: 109-115.
29. Eberts TJ, Sample RHB, Glick, et al. A simplified, colorimetric micromethod for xylose in serum or urine, with phloroglucinol. Clin Chem 1979; 25: 1440-1443.et al.
30. Paulsen SJ, Vrang N, Larsen LK, et al. Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function. J Anat 2010; 217: 624-630.
31. Patriti A, Aisa MC, Annetti C, et al. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced proglucagon gene expression and L-cell number. Surgery 2007; 142: 74-85.
32. Peterli R, Wolnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009; 250: 234-241.
33. Mason EE,. The mechanisms of surgical treatment of type 2 diabetes. Obes Surg 2005; 15: 459-461.
34. Geloneze B, Geloneze SR, Chaim E, et al. Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study. Ann Surg 2012; 256: 72-78.
35. Pacheco D, de Luis DA, Romero A, et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg 2007; 194: 221-224.
36. Kindel TL, Yoder SM, Seeley RJ, et al. Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. J Gastrointest Surg 2009; 13: 1762-1772.
37. Troy S, Soty M, Ribeiro L, et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008; 8: 201-211.
38. McLaughlin T, Peck M, Holst J, et al. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab 2010; 95: 1851-1855.
39. Kieffer TJ, Habener JF,. The glucagon-like peptides. Endocr Rev 1999; 20: 876-913.
40. Stylopoulos N, Hoppin AG, Kaplan LM,. Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats. Obesity (Silver Spring) 2009; 17: 1839-1847.